Secondary analysis of a non-drug insomnia therapy trial: insomnia severity fell in both cognitively intact (n=87) and MCI (n=38) older adults, with no difference post-treatment, but at 6 months the intact group improved more (p=0.036; meaningful reduction 78.7% vs 45.8%).
Secondary analysisn = 125
O'Hora et al. Cognitive status moderates long-term benefits of non-pharmacological insomnia therapy in older adults: A secondary analysis of a randomized clinical trial